Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Journey Medical (DERM) Equity Average: 2021-2024

Historic Equity Average for Journey Medical (DERM) over the last 4 years, with Dec 2024 value amounting to $20.2 million.

  • Journey Medical's Equity Average rose 103.16% to $22.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.6 million, marking a year-over-year increase of 103.16%. This contributed to the annual value of $20.2 million for FY2024, which is 8.27% up from last year.
  • Journey Medical's Equity Average amounted to $20.2 million in FY2024, which was up 8.27% from $18.7 million recorded in FY2023.
  • In the past 5 years, Journey Medical's Equity Average ranged from a high of $29.5 million in FY2022 and a low of $18.7 million during FY2023.
  • Its 3-year average for Equity Average is $22.8 million, with a median of $20.2 million in 2024.
  • As far as peak fluctuations go, Journey Medical's Equity Average climbed by 12.78% in 2022, and later plummeted by 36.75% in 2023.
  • Over the past 4 years, Journey Medical's Equity Average (Yearly) stood at $26.2 million in 2021, then grew by 12.78% to $29.5 million in 2022, then plummeted by 36.75% to $18.7 million in 2023, then rose by 8.27% to $20.2 million in 2024.